Global Receptor Tyrosine Protein Kinase ERBB 4 Market Insights and Forecast to 2026

世界の受容体チロシンプロテインキナーゼERBB4市場2026:インサイト・予測

◆タイトル:Global Receptor Tyrosine Protein Kinase ERBB 4 Market Insights and Forecast to 2026
◆商品コード:QYR20NV08957
◆調査・発行会社:QYResearch
◆発行日:2020年11月
◆ページ数:110
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートは受容体チロシンプロテインキナーゼERBB4の世界市場について調査・分析した資料です。種類別(PB-357、NT-113、NRG-4、MIN-301、その他)の市場規模、用途別(皮膚がん、収縮期心不全、神経芽細胞腫、乏突起膠腫、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別受容体チロシンプロテインキナーゼERBB4の競争状況、市場シェア
・世界の受容体チロシンプロテインキナーゼERBB4市場:種類別市場規模 2015年-2020年(PB-357、NT-113、NRG-4、MIN-301、その他)
・世界の受容体チロシンプロテインキナーゼERBB4市場:種類別市場規模予測 2021年-2026年(PB-357、NT-113、NRG-4、MIN-301、その他)
・世界の受容体チロシンプロテインキナーゼERBB4市場:用途別市場規模 2015年-2020年(皮膚がん、収縮期心不全、神経芽細胞腫、乏突起膠腫、その他)
・世界の受容体チロシンプロテインキナーゼERBB4市場:用途別市場規模予測 2021年-2026年(皮膚がん、収縮期心不全、神経芽細胞腫、乏突起膠腫、その他)
・北米の受容体チロシンプロテインキナーゼERBB4市場分析:米国、カナダ
・ヨーロッパの受容体チロシンプロテインキナーゼERBB4市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの受容体チロシンプロテインキナーゼERBB4市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の受容体チロシンプロテインキナーゼERBB4市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの受容体チロシンプロテインキナーゼERBB4市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Aslan Pharmaceuticals Pte Ltd、Boehringer Ingelheim GmbH、GamaMabs Pharma SA、Hanmi Pharmaceuticals Co Ltd、Jiangsu Kanion Pharmaceutical Co Ltd、Minerva Neurosciences Inc、Pfizer Inc、Puma Biotechnology Inc、Shanghai Fosun Pharmaceutical (Group) Co Ltd、XuanZhu Pharma Co Ltd、Zensun (Shanghai) Sci & Tech Co Ltd
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Receptor Tyrosine Protein Kinase ERBB 4 Market
The global Receptor Tyrosine Protein Kinase ERBB 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Receptor Tyrosine Protein Kinase ERBB 4 Scope and Market Size
Receptor Tyrosine Protein Kinase ERBB 4 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Receptor Tyrosine Protein Kinase ERBB 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Receptor Tyrosine Protein Kinase ERBB 4 market is segmented into
PB-357
NT-113
NRG-4
MIN-301
Others

Segment by Application, the Receptor Tyrosine Protein Kinase ERBB 4 market is segmented into
Skin Cancer
Systolic Heart Failure
Neuroblastoma
Oligodendroglioma
Others

Regional and Country-level Analysis
The Receptor Tyrosine Protein Kinase ERBB 4 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Receptor Tyrosine Protein Kinase ERBB 4 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Receptor Tyrosine Protein Kinase ERBB 4 Market Share Analysis
Receptor Tyrosine Protein Kinase ERBB 4 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Receptor Tyrosine Protein Kinase ERBB 4 business, the date to enter into the Receptor Tyrosine Protein Kinase ERBB 4 market, Receptor Tyrosine Protein Kinase ERBB 4 product introduction, recent developments, etc.

The major vendors covered:
Aslan Pharmaceuticals Pte Ltd
Boehringer Ingelheim GmbH
GamaMabs Pharma SA
Hanmi Pharmaceuticals Co Ltd
Jiangsu Kanion Pharmaceutical Co Ltd
Minerva Neurosciences Inc
Pfizer Inc
Puma Biotechnology Inc
Shanghai Fosun Pharmaceutical (Group) Co Ltd
XuanZhu Pharma Co Ltd
Zensun (Shanghai) Sci & Tech Co Ltd

【レポートの目次】

1 Study Coverage
1.1 Receptor Tyrosine Protein Kinase ERBB 4 Product Introduction
1.2 Market Segments
1.3 Key Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Growth Rate by Type
1.4.2 PB-357
1.4.3 NT-113
1.4.4 NRG-4
1.4.5 MIN-301
1.4.6 Others
1.5 Market by Application
1.5.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Growth Rate by Application
1.5.2 Skin Cancer
1.5.3 Systolic Heart Failure
1.5.4 Neuroblastoma
1.5.5 Oligodendroglioma
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size, Estimates and Forecasts
2.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue 2015-2026
2.1.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales 2015-2026
2.2 Global Receptor Tyrosine Protein Kinase ERBB 4, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Receptor Tyrosine Protein Kinase ERBB 4 Competitor Landscape by Players
3.1 Receptor Tyrosine Protein Kinase ERBB 4 Sales by Manufacturers
3.1.1 Receptor Tyrosine Protein Kinase ERBB 4 Sales by Manufacturers (2015-2020)
3.1.2 Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Manufacturers (2015-2020)
3.2 Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Manufacturers
3.2.1 Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Manufacturers (2015-2020)
3.2.2 Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Receptor Tyrosine Protein Kinase ERBB 4 Revenue in 2019
3.2.5 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Receptor Tyrosine Protein Kinase ERBB 4 Price by Manufacturers
3.4 Receptor Tyrosine Protein Kinase ERBB 4 Manufacturing Base Distribution, Product Types
3.4.1 Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Receptor Tyrosine Protein Kinase ERBB 4 Product Type
3.4.3 Date of International Manufacturers Enter into Receptor Tyrosine Protein Kinase ERBB 4 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Type (2015-2020)
4.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2015-2020)
4.1.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2015-2020)
4.1.3 Receptor Tyrosine Protein Kinase ERBB 4 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Forecast by Type (2021-2026)
4.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Type (2021-2026)
4.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Type (2021-2026)
4.2.3 Receptor Tyrosine Protein Kinase ERBB 4 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Application (2015-2020)
5.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2015-2020)
5.1.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2015-2020)
5.1.3 Receptor Tyrosine Protein Kinase ERBB 4 Price by Application (2015-2020)
5.2 Receptor Tyrosine Protein Kinase ERBB 4 Market Size Forecast by Application (2021-2026)
5.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Application (2021-2026)
5.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Application (2021-2026)
5.2.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Receptor Tyrosine Protein Kinase ERBB 4 by Country
6.1.1 North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country
6.1.2 North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Type
6.3 North America Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Application

7 Europe
7.1 Europe Receptor Tyrosine Protein Kinase ERBB 4 by Country
7.1.1 Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country
7.1.2 Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Type
7.3 Europe Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 by Region
8.1.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region
8.1.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Type
8.3 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Receptor Tyrosine Protein Kinase ERBB 4 by Country
9.1.1 Latin America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country
9.1.2 Latin America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Type
9.3 Central & South America Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 by Country
10.1.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country
10.1.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Type
10.3 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Application

11 Company Profiles
11.1 Aslan Pharmaceuticals Pte Ltd
11.1.1 Aslan Pharmaceuticals Pte Ltd Corporation Information
11.1.2 Aslan Pharmaceuticals Pte Ltd Description and Business Overview
11.1.3 Aslan Pharmaceuticals Pte Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Products Offered
11.1.5 Aslan Pharmaceuticals Pte Ltd Related Developments
11.2 Boehringer Ingelheim GmbH
11.2.1 Boehringer Ingelheim GmbH Corporation Information
11.2.2 Boehringer Ingelheim GmbH Description and Business Overview
11.2.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Products Offered
11.2.5 Boehringer Ingelheim GmbH Related Developments
11.3 GamaMabs Pharma SA
11.3.1 GamaMabs Pharma SA Corporation Information
11.3.2 GamaMabs Pharma SA Description and Business Overview
11.3.3 GamaMabs Pharma SA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Products Offered
11.3.5 GamaMabs Pharma SA Related Developments
11.4 Hanmi Pharmaceuticals Co Ltd
11.4.1 Hanmi Pharmaceuticals Co Ltd Corporation Information
11.4.2 Hanmi Pharmaceuticals Co Ltd Description and Business Overview
11.4.3 Hanmi Pharmaceuticals Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Products Offered
11.4.5 Hanmi Pharmaceuticals Co Ltd Related Developments
11.5 Jiangsu Kanion Pharmaceutical Co Ltd
11.5.1 Jiangsu Kanion Pharmaceutical Co Ltd Corporation Information
11.5.2 Jiangsu Kanion Pharmaceutical Co Ltd Description and Business Overview
11.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Products Offered
11.5.5 Jiangsu Kanion Pharmaceutical Co Ltd Related Developments
11.6 Minerva Neurosciences Inc
11.6.1 Minerva Neurosciences Inc Corporation Information
11.6.2 Minerva Neurosciences Inc Description and Business Overview
11.6.3 Minerva Neurosciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Products Offered
11.6.5 Minerva Neurosciences Inc Related Developments
11.7 Pfizer Inc
11.7.1 Pfizer Inc Corporation Information
11.7.2 Pfizer Inc Description and Business Overview
11.7.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Products Offered
11.7.5 Pfizer Inc Related Developments
11.8 Puma Biotechnology Inc
11.8.1 Puma Biotechnology Inc Corporation Information
11.8.2 Puma Biotechnology Inc Description and Business Overview
11.8.3 Puma Biotechnology Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Products Offered
11.8.5 Puma Biotechnology Inc Related Developments
11.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
11.9.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporation Information
11.9.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Description and Business Overview
11.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Products Offered
11.9.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Related Developments
11.10 XuanZhu Pharma Co Ltd
11.10.1 XuanZhu Pharma Co Ltd Corporation Information
11.10.2 XuanZhu Pharma Co Ltd Description and Business Overview
11.10.3 XuanZhu Pharma Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.10.4 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Products Offered
11.10.5 XuanZhu Pharma Co Ltd Related Developments
11.1 Aslan Pharmaceuticals Pte Ltd
11.1.1 Aslan Pharmaceuticals Pte Ltd Corporation Information
11.1.2 Aslan Pharmaceuticals Pte Ltd Description and Business Overview
11.1.3 Aslan Pharmaceuticals Pte Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Products Offered
11.1.5 Aslan Pharmaceuticals Pte Ltd Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Receptor Tyrosine Protein Kinase ERBB 4 Market Estimates and Projections by Region
12.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Regions 2021-2026
12.1.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Regions 2021-2026
12.2 North America Receptor Tyrosine Protein Kinase ERBB 4 Market Size Forecast (2021-2026)
12.2.1 North America: Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast (2021-2026)
12.2.2 North America: Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast (2021-2026)
12.2.3 North America: Receptor Tyrosine Protein Kinase ERBB 4 Market Size Forecast by Country (2021-2026)
12.3 Europe Receptor Tyrosine Protein Kinase ERBB 4 Market Size Forecast (2021-2026)
12.3.1 Europe: Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast (2021-2026)
12.3.2 Europe: Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast (2021-2026)
12.3.3 Europe: Receptor Tyrosine Protein Kinase ERBB 4 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Receptor Tyrosine Protein Kinase ERBB 4 Market Size Forecast by Region (2021-2026)
12.5 Latin America Receptor Tyrosine Protein Kinase ERBB 4 Market Size Forecast (2021-2026)
12.5.1 Latin America: Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast (2021-2026)
12.5.2 Latin America: Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast (2021-2026)
12.5.3 Latin America: Receptor Tyrosine Protein Kinase ERBB 4 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Receptor Tyrosine Protein Kinase ERBB 4 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Receptor Tyrosine Protein Kinase ERBB 4 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Receptor Tyrosine Protein Kinase ERBB 4 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Receptor Tyrosine Protein Kinase ERBB 4 Market Segments
Table 2. Ranking of Global Top Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of PB-357
Table 5. Major Manufacturers of NT-113
Table 6. Major Manufacturers of NRG-4
Table 7. Major Manufacturers of MIN-301
Table 8. Major Manufacturers of Others
Table 9. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Regions (2015-2020)
Table 13. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Manufacturers (2015-2020)
Table 16. Global Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Receptor Tyrosine Protein Kinase ERBB 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Receptor Tyrosine Protein Kinase ERBB 4 as of 2019)
Table 18. Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 4 Price (2015-2020) (USD/Pcs)
Table 21. Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Receptor Tyrosine Protein Kinase ERBB 4 Product Type
Table 23. Date of International Manufacturers Enter into Receptor Tyrosine Protein Kinase ERBB 4 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Type (2015-2020)
Table 27. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Type (2015-2020)
Table 29. Receptor Tyrosine Protein Kinase ERBB 4 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Application (2015-2020)
Table 32. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2015-2020)
Table 34. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2015-2020)
Table 36. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2015-2020)
Table 38. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2015-2020)
Table 40. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2015-2020)
Table 42. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2015-2020)
Table 44. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2015-2020)
Table 46. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2015-2020)
Table 56. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2015-2020)
Table 62. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2015-2020)
Table 72. Aslan Pharmaceuticals Pte Ltd Corporation Information
Table 73. Aslan Pharmaceuticals Pte Ltd Description and Major Businesses
Table 74. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Aslan Pharmaceuticals Pte Ltd Product
Table 76. Aslan Pharmaceuticals Pte Ltd Recent Development
Table 77. Boehringer Ingelheim GmbH Corporation Information
Table 78. Boehringer Ingelheim GmbH Description and Major Businesses
Table 79. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Boehringer Ingelheim GmbH Product
Table 81. Boehringer Ingelheim GmbH Recent Development
Table 82. GamaMabs Pharma SA Corporation Information
Table 83. GamaMabs Pharma SA Description and Major Businesses
Table 84. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. GamaMabs Pharma SA Product
Table 86. GamaMabs Pharma SA Recent Development
Table 87. Hanmi Pharmaceuticals Co Ltd Corporation Information
Table 88. Hanmi Pharmaceuticals Co Ltd Description and Major Businesses
Table 89. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Hanmi Pharmaceuticals Co Ltd Product
Table 91. Hanmi Pharmaceuticals Co Ltd Recent Development
Table 92. Jiangsu Kanion Pharmaceutical Co Ltd Corporation Information
Table 93. Jiangsu Kanion Pharmaceutical Co Ltd Description and Major Businesses
Table 94. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Jiangsu Kanion Pharmaceutical Co Ltd Product
Table 96. Jiangsu Kanion Pharmaceutical Co Ltd Recent Development
Table 97. Minerva Neurosciences Inc Corporation Information
Table 98. Minerva Neurosciences Inc Description and Major Businesses
Table 99. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Minerva Neurosciences Inc Product
Table 101. Minerva Neurosciences Inc Recent Development
Table 102. Pfizer Inc Corporation Information
Table 103. Pfizer Inc Description and Major Businesses
Table 104. Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Pfizer Inc Product
Table 106. Pfizer Inc Recent Development
Table 107. Puma Biotechnology Inc Corporation Information
Table 108. Puma Biotechnology Inc Description and Major Businesses
Table 109. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Puma Biotechnology Inc Product
Table 111. Puma Biotechnology Inc Recent Development
Table 112. Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporation Information
Table 113. Shanghai Fosun Pharmaceutical (Group) Co Ltd Description and Major Businesses
Table 114. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Shanghai Fosun Pharmaceutical (Group) Co Ltd Product
Table 116. Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Development
Table 117. XuanZhu Pharma Co Ltd Corporation Information
Table 118. XuanZhu Pharma Co Ltd Description and Major Businesses
Table 119. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. XuanZhu Pharma Co Ltd Product
Table 121. XuanZhu Pharma Co Ltd Recent Development
Table 122. Zensun (Shanghai) Sci & Tech Co Ltd Corporation Information
Table 123. Zensun (Shanghai) Sci & Tech Co Ltd Description and Major Businesses
Table 124. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Zensun (Shanghai) Sci & Tech Co Ltd Product
Table 126. Zensun (Shanghai) Sci & Tech Co Ltd Recent Development
Table 127. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 128. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share Forecast by Regions (2021-2026)
Table 129. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 130. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share Forecast by Regions (2021-2026)
Table 131. North America: Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 132. North America: Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Europe: Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 134. Europe: Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Asia Pacific: Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Region (2021-2026) (K Pcs)
Table 136. Asia Pacific: Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 137. Latin America: Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 138. Latin America: Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Middle East and Africa: Receptor Tyrosine Protein Kinase ERBB 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 140. Middle East and Africa: Receptor Tyrosine Protein Kinase ERBB 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 142. Key Challenges
Table 143. Market Risks
Table 144. Main Points Interviewed from Key Receptor Tyrosine Protein Kinase ERBB 4 Players
Table 145. Receptor Tyrosine Protein Kinase ERBB 4 Customers List
Table 146. Receptor Tyrosine Protein Kinase ERBB 4 Distributors List
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Receptor Tyrosine Protein Kinase ERBB 4 Product Picture
Figure 2. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type in 2020 & 2026
Figure 3. PB-357 Product Picture
Figure 4. NT-113 Product Picture
Figure 5. NRG-4 Product Picture
Figure 6. MIN-301 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application in 2020 & 2026
Figure 9. Skin Cancer
Figure 10. Systolic Heart Failure
Figure 11. Neuroblastoma
Figure 12. Oligodendroglioma
Figure 13. Others
Figure 14. Receptor Tyrosine Protein Kinase ERBB 4 Report Years Considered
Figure 15. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size 2015-2026 (US$ Million)
Figure 16. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales 2015-2026 (K Pcs)
Figure 17. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region (2015-2020)
Figure 19. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region in 2019
Figure 20. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region (2015-2020)
Figure 21. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region in 2019
Figure 22. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Receptor Tyrosine Protein Kinase ERBB 4 Revenue in 2019
Figure 24. Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2015-2020)
Figure 26. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type in 2019
Figure 27. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type (2015-2020)
Figure 28. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type in 2019
Figure 29. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Price Range (2015-2020)
Figure 30. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2015-2020)
Figure 31. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application in 2019
Figure 32. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application (2015-2020)
Figure 33. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application in 2019
Figure 34. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country in 2019
Figure 37. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country in 2019
Figure 38. U.S. Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Type in 2019
Figure 43. North America Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Application in 2019
Figure 44. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country in 2019
Figure 47. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country in 2019
Figure 48. Germany Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Type in 2019
Figure 59. Europe Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Application in 2019
Figure 60. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region in 2019
Figure 63. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region in 2019
Figure 64. China Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Type in 2019
Figure 87. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Application in 2019
Figure 88. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country in 2019
Figure 91. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country in 2019
Figure 92. Mexico Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Type in 2019
Figure 99. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Application in 2019
Figure 100. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country in 2019
Figure 104. Turkey Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Type in 2019
Figure 111. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Market Share by Application in 2019
Figure 112. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の受容体チロシンプロテインキナーゼERBB4市場2026:インサイト・予測] (Global Receptor Tyrosine Protein Kinase ERBB 4 Market Insights and Forecast to 2026 / QYR20NV08957)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆